Fuziiigraf 2 – Overview
Fuziiigraf 2 mg by Hospimax contains Tacrolimus, a potent immunosuppressant used to prevent organ rejection in transplant patients. It works by inhibiting T-cell activation, reducing immune responses that may damage the transplanted organ. Tacrolimus is commonly prescribed after kidney, liver, or heart transplants and is often used in combination with other immunosuppressive medications.
Benefits of Fuziiigraf 2 Mg:
- Prevents Organ Rejection: Helps kidney, liver, and heart transplant patients by suppressing immune responses.
- Precise Immunosuppression: Targets specific immune cells, reducing the risk of graft rejection while minimizing side effects.
- Alternative to Cyclosporine: Offers an effective option for patients intolerant to cyclosporine-based immunosuppressants.
- Convenient Oral Administration: Available in capsule form, making it easy for patients to follow their prescribed regimen.
- Manufactured with High-Quality Standards: Ensures potency, purity, and safety under strict regulatory guidelines.
Specification/Additional Details:
- Strength: 2 mg
- Packaging Type: Blister Pack
- Packaging Size: Typically available in strips of 10 or 30 capsules
- Brand: Fuziiigraf
- Manufactured By: Hospimax
- Country of Origin: (India)
For bulk purchase inquiries, pricing details, and more specifications, please contact us.
Reviews
There are no reviews yet.